Gilead Sciences, Inc.
MarketLine (a Datamonitor Company)
08 Apr 2014
Available for Immediate Download
Gilead Sciences, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis - An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments - Intelligence on Gilead Sciences, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Gilead Sciences (Gilead or 'the company') is a biopharmaceutical company engaged in developing and marketing therapies for HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions. The company operates in North America, Europe and Australia. It is headquartered in Foster City, California, and employed about 5,000 people as of January 31, 2013. The company recorded revenues of $9,702.5 million during the financial year ended December 2012 (FY2012), an increase of 15.7% over FY2011. The operating profit of the company was $4,010.2 million in FY2012, an increase of 5.8% over FY2011. The net profit was $2,591.6 million in FY2012, a decrease of 7.6% over FY2011. Reasons to Purchase: - Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Gilead Sciences, Inc.’s business structure, strategy and prospects